Is Avenue Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ATXI) stock is to Strong Buy ATXI stock.
Out of 1 analyst, 1 (100%) are recommending ATXI as a Strong Buy, 0 (0%) are recommending ATXI as a Buy, 0 (0%) are recommending ATXI as a Hold, 0 (0%) are recommending ATXI as a Sell, and 0 (0%) are recommending ATXI as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year ATXI price target, the average ATXI price target is $32.00, with the highest ATXI stock price forecast at $32.00 and the lowest ATXI stock price forecast at $32.00.
The Wall Street analyst predicted that Avenue Therapeutics's share price could reach $32.00 by Apr 3, 2024. The average Avenue Therapeutics stock price prediction forecasts a potential upside of 2,782.88% from the current ATXI share price of $1.11.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.